Therapeutic Area - Gastrointestinal Solutions
During drug development, many key datapoints are related to physiology of the gastrointestinal (GI) tract. Many disease conditions are also associated with an alteration of the anatomy and/or physiology of the GI tract. For this reason, it is important for a CRO should have an established history of gastrointestinal studies.
KCAS is ready to begin your gastrointestinal drug development project
KCAS has extensive experience in conducting gastrointestinal studies. Our team is made up of dedicated drug development experts with significant experience in conducting studies for experimental therapeutics for diseases and conditions that include everything from acid reflux and indigestion to IBS and Celiac.